Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P97
Near historical high
vs 2Y Ago
4.7x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 140.50% |
| Q2 2025 | 14.64% |
| Q1 2025 | -192.94% |
| Q4 2024 | 33.18% |
| Q3 2024 | 73.70% |
| Q2 2024 | -121.48% |
| Q1 2024 | 903.44% |
| Q4 2023 | -76.09% |
| Q3 2023 | 30.06% |
| Q2 2023 | 29.25% |
| Q1 2023 | 18.01% |
| Q4 2022 | -35.77% |
| Q3 2022 | -47.79% |
| Q2 2022 | -18.70% |
| Q1 2022 | 11.99% |
| Q4 2021 | -9.70% |
| Q3 2021 | 33.17% |
| Q2 2021 | -23.18% |
| Q1 2021 | -9.41% |
| Q4 2020 | 39.70% |
| Q3 2020 | -74.78% |
| Q2 2020 | 16.88% |
| Q1 2020 | -135.79% |
| Q4 2019 | 28.86% |
| Q3 2019 | 18.90% |
| Q2 2019 | -11.17% |
| Q1 2019 | 15.39% |
| Q4 2018 | -83.24% |
| Q3 2018 | -1.85% |
| Q2 2018 | 9.09% |
| Q1 2018 | -30.83% |
| Q4 2017 | -37.79% |
| Q3 2017 | -39.24% |
| Q2 2017 | -1.93% |
| Q1 2017 | -10.47% |
| Q4 2016 | -12.32% |
| Q3 2016 | -15.74% |
| Q2 2016 | 5.81% |
| Q1 2016 | -17.69% |
| Q4 2015 | 16.70% |